Stocks to Watch: Micron, Warner Bros. Discovery, Paramount Global, Calliditas Therapeutics
21 December 2023 - 11:00AM
Dow Jones News
By Ben Glickman
Micron Technology issued a better-than-expected outlook for the
current quarter, forecasting a sharp rise in revenue. The
memory-chip maker said strong pricing and demand for chips to
support artificial intelligence boosted results in the fiscal first
quarter, with the company reporting a narrower-than-expected loss.
Shares rose 4.3%, to $82.11, after-hours.
Warner Bros. Discovery Chief Executive David Zaslav met with
Paramount CEO Bob Bakish this week and discussed a possible merger,
though no formal talks between the companies are under way. Warner
Bros. Discovery shares fell 1.6% after-hours, while Paramount
shares sank 1.7%.
Calliditas Therapeutics received full approval from the U.S.
Food and Drug Adminstration for Tarpeyo as a treatment for patients
with primary immunoglobulin A nephropathy. The treatment is the
first fully FDA-approved treatment for IgAN, a disease in the
kidneys, based on a measure of kidney function, the company said.
Shares rose 25%, to $28, after-hours.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
December 20, 2023 18:45 ET (23:45 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Calliditas Therapeutics AB (NASDAQ:CALT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Calliditas Therapeutics AB (NASDAQ:CALT)
Historical Stock Chart
From Jul 2023 to Jul 2024